Issue
Date Log
Copyright (c) 2026 Hamdan Ali Alshehri, Renad A. Saigh, Raheem M. Balkhtb, Faisal Ali Naif Alanazi, Alaa Salman Jubran Khubrani, Latifa Fareed Althawab, Asma Ghzzai Almutairi Almutairi, Lina Nabhan, Maryam Mohammed Alqahtani, Shahad Abdulrahman Alluhaymid

This work is licensed under a Creative Commons Attribution 4.0 International License.
Alkaline Phosphatase in Clinical Laboratory Medicine: Biochemistry, Isoenzymes, and Diagnostic Applications-An Updated Review
Corresponding Author(s) : Hamdan Ali Alshehri
Saudi Journal of Medicine and Public Health,
Vol. 3 No. 1 (2026)
Abstract
Background: Alkaline phosphatase (ALP) is an important clinical laboratory enzyme associated primarily with hepatobiliary function and bone metabolism. Abnormal serum ALP activity may indicate cholestatic liver disease, increased bone turnover, or other physiological and pathological conditions. Accurate measurement and interpretation are therefore essential for appropriate clinical decision-making.
Aim: This review examines the biochemical characteristics of ALP, its physiological and pathological variations, laboratory measurement techniques, diagnostic applications, and clinical significance, with emphasis on quality control and laboratory safety.
Methods: A narrative review approach was used to summarize published information on ALP biochemistry, tissue-specific isoenzymes, specimen requirements, analytical methods, interfering factors, quality assurance, and clinical interpretation. Relevant diagnostic applications and laboratory practices were also examined.
Results: Serum ALP originates mainly from hepatic and bone tissues, although intestinal, placental, and other isoenzymes may contribute to circulating activity. Increased ALP is particularly associated with cholestasis, biliary obstruction, infiltrative liver diseases, and disorders involving increased bone turnover. GGT and 5'-nucleotidase measurements, alongside isoenzyme analysis, help establish the tissue source. Analytical accuracy depends on appropriate specimen collection, validated measurement procedures, reagent quality, and effective internal and external quality control. Biological variation, medications, hemolysis, lipemia, and assay-specific interference may affect results.
Conclusion: ALP remains a valuable biochemical marker for evaluating hepatobiliary and skeletal disorders. Reliable clinical interpretation requires integration of laboratory findings with patient characteristics, complementary investigations, and appropriate quality management.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- 1. Green MR, Sambrook J. Alkaline Phosphatase. Cold Spring Harb Protoc. 2020 Aug 03;2020(8):100768.
- 2. Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020 Sep 05;754:144855.
- 3. Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue Non-Specific Alkaline Phosphatase and Vascular Calcification: A Potential Therapeutic Target. Curr Cardiol Rev. 2019;15(2):91-95.
- 4. Zaher DM, El-Gamal MI, Omar HA, Aljareh SN, Al-Shamma SA, Ali AJ, Zaib S, Iqbal J. Recent advances with alkaline phosphatase isoenzymes and their inhibitors. Arch Pharm (Weinheim). 2020 May;353(5):e2000011.
- 5. Lallès JP. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev. 2014 Feb;72(2):82-94.
- 6. Dixon IMC. Tissue non-specific alkaline phosphatase (TNAP): A player in post-MI cardiac fibrosis. EBioMedicine. 2021 Jun;68:103430.
- 7. Brichacek AL, Brown CM. Alkaline phosphatase: a potential biomarker for stroke and implications for treatment. Metab Brain Dis. 2019 Feb;34(1):3-19.
- 8. Crofton PM. Biochemistry of alkaline phosphatase isoenzymes. Crit Rev Clin Lab Sci. 1982;16(3):161-94.
- 9. Matsushita M, Harajiri S, Tabata S, Yukimasa N, Muramoto Y, Komoda T. [Alkaline phosphatase activity in blood group B or O secretors is fluctuated by the dinner intake of previous night]. Rinsho Byori. 2013 Apr;61(4):307-12.
- 10. Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014 Jul;29(3):269-78.
- 11. Masrour Roudsari J, Mahjoub S. Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget's specimens. Caspian J Intern Med. 2012 Summer;3(3):478-83.
- 12. Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. Biochim Biophys Acta. 2013 Dec;1832(12):2044-56.
- 13. Wieczorek E. [Nocturnal intragastric administration of phosphates in the treatment of familial hypophosphatemic rickets]. Pediatr Pol. 1986 Sep;61(9):563-70.
- 14. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44(6):750-9.
- 15. McDonough PG. Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril. 2002 Apr;77(4):857-8.
- 16. Sancenon V, Goh WH, Sundaram A, Er KS, Johal N, Mukhina S, Carr G, Dhakshinamoorthy S. Development, validation and quantitative assessment of an enzymatic assay suitable for small molecule screening and profiling: A case-study. Biomol Detect Quantif. 2015 Jun;4:1-9.
- 17. Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER. A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem. 1983 May;29(5):751-61.
- 18. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013 Jan;257(1):27-36.
- 19. Siede WH, Seiffert UB. Quantitative alkaline phosphatase isoenzyme determination by electrophoresis on cellulose acetate membranes. Clin Chem. 1977 Jan;23(1):28-34.
- 20. Ni P, Xie J, Chen C, Jiang Y, Zhao Z, Zhang Y, Lu Y, Yu J. Spectrophotometric determination of the activity of alkaline phosphatase and detection of its inhibitors by exploiting the pyrophosphate-accelerated oxidase-like activity of nanoceria. Mikrochim Acta. 2019 May 02;186(5):320.
- 21. Wang J, Ni P, Chen C, Jiang Y, Zhang C, Wang B, Cao B, Lu Y. Colorimetric determination of the activity of alkaline phosphatase by exploiting the oxidase-like activity of palladium cube@CeO2 core-shell nanoparticles. Mikrochim Acta. 2020 Jan 09;187(2):115.
- 22. Warnes TW, Hine P, Kay G. Polyacrylamide gel disc electrophoresis of alkaline phosphatase isoenzymes in bone and liver disease. J Clin Pathol. 1976 Sep;29(9):782-7.
- 23. Milinković N, Sarić-Matutinović M, Pejanović S, Ignjatović S. Comparison between bone alkaline phosphatase immunoassay and electrophoresis technique in hemodialysis patients. J Med Biochem. 2020 Jan 23;39(2):178-183.
- 24. Rosalki SB, Foo AY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984 Jul;30(7):1182-6.
- 25. Moss DW. Alkaline phosphatase isoenzymes. Clin Chem. 1982 Oct;28(10):2007-16.
- 26. Iino S. [Clinical significance of alkaline phosphatase isozyme analysis]. Nihon Rinsho. 1995 May;53(5):1157-61.
- 27. Farley JR, Hall SL, Herring S, Libanati C, Wergedal JE. Reference standards for quantification of skeletal alkaline phosphatase activity in serum by heat inactivation and lectin precipitation. Clin Chem. 1993 Sep;39(9):1878-84.
- 28. Puukka R. Comparison of alkaline phosphatase isoenzymes determined by an inhibition method and by electrophoresis. Clin Chim Acta. 1978 Apr 17;85(2):111-4.
- 29. Fishman WH. Immunology and biochemistry of the Regan isoenzyme. Prostate. 1980;1(4):399-410.
- 30. Moss DW. Diagnostic aspects of alkaline phosphatase and its isoenzymes. Clin Biochem. 1987 Aug;20(4):225-30.
- 31. Nozawa S, Arai H, Widjaja T, Tsukazaki K, Ohta H, Kurihara S. [Biochemical studies on alkaline phosphatase isoenzyme profile in endometrial cancer]. Nihon Sanka Fujinka Gakkai Zasshi. 1984 Mar;36(3):369-76.
- 32. Jardillier JC. [The isoenzymes of the alkaline phosphatases and their cancerologic biochemistries prospects (author's transl)]. Ann Biol Clin (Paris). 1981;39(3):115-20.
- 33. Bowen RA, Remaley AT. Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb). 2014;24(1):31-44.
- 34. Knaak JB, Leung HW, Stott WT, Busch J, Bilsky J. Toxicology of mono-, di-, and triethanolamine. Rev Environ Contam Toxicol. 1997;149:1-86.
- 35. Niina N, Kodamatani H, Uozumi K, Kokufu Y, Saito K, Yamazaki S. Simultaneous detection of monoethanolamine, diethanolamine, and triethanolamine by HPLC with a chemiluminescence reaction and online derivatization to tertiary amine. Anal Sci. 2005 May;21(5):497-500.
- 36. Horning K, Schmidt C. Azathioprine-Induced Rapid Hepatotoxicity. J Pharm Technol. 2014 Feb;30(1):18-20.
- 37. Fraser MO, Arslan M, Plant TM. Androgen and estrogen treatment, alone or in combination, differentially influences bone maturation and hypothalamic mechanisms that time puberty in the male rhesus monkey (Macaca mulatta). Pediatr Res. 2005 Jan;57(1):141-8.
- 38. Sjödén G, Rosenqvist M, Kriegholm E, Nordenström J, Björkhem I. Verapamil increases serum alkaline phosphatase in hypertensive patients. J Intern Med. 1990 Oct;228(4):339-42.
- 39. David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev. 2010 Jan 01;6:73-80.
- 40. Wang Z, Guo H, Wang Y, Kong F, Wang R. Interfering effect of bilirubin on the determination of alkaline phosphatase. Int J Clin Exp Med. 2014;7(11):4244-8.
- 41. Pyles LA, Stejskal EJ, Einzig S. Spectrophotometric measurement of plasma 2-thiobarbituric acid-reactive substances in the presence of hemoglobin and bilirubin interference. Proc Soc Exp Biol Med. 1993 Apr;202(4):407-19.
- 42. Stigbrand T. Present status and future trends of human alkaline phosphatases. Prog Clin Biol Res. 1984;166:3-14.
- 43. Martin JM, Goldberg DM. Activities of gamma-glutamyl transferase, 5'-nucleotidase and alkaline phosphatase in human duodenal aspirate. Enzyme. 1986;35(4):189-96.
- 44. Takeuchi A, Shibuya A. [5'-Nucleotidase]. Nihon Rinsho. 1999 Aug;57 Suppl:483-5.
- 45. Shamban L, Patel B, Williams M. Significantly Elevated Liver Alkaline Phosphatase in Congestive Heart Failure. Gastroenterology Res. 2014 Apr;7(2):64-68.
- 46. Gao Y, Chin K, Mishriki YY. AIDS Cholangiopathy in an Asymptomatic, Previously Undiagnosed Late-Stage HIV-Positive Patient from Kenya. Int J Hepatol. 2011;2011:465895.
- 47. Šmíd V. Liver tests. Cas Lek Cesk. 2022 Spring;161(2):52-56.
- 48. Demers LM, Costa L, Lipton A. Biochemical markers and skeletal metastases. Cancer. 2000 Jun 15;88(12 Suppl):2919-26.
- 49. Fontes-Sousa M, Magalhães H, da Silva FC, Maurício MJ. Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria. Urol Oncol. 2018 Jul;36(7):321-326.
- 50. Sakurai Y, Higashiguchi T. Transient hyperphosphatasemia: Possible association with pediatric acute respiratory infection. Pediatr Investig. 2021 Jun;5(2):94-98.
- 51. Whyte MP. Hypophosphatasia: An overview For 2017. Bone. 2017 Sep;102:15-25.
- 52. Arthur LJ, Hill PG, Attenburrow AA. Transient hyperphosphatasaemia. Arch Dis Child. 1984 Oct;59(10):996-7.
- 53. Schonhaut B L, Rocha R A. [Benign transient hyperphosphatasaemia in infants: Clinical series]. Rev Chil Pediatr. 2017 Feb;88(1):169-175.
- 54. Verma J, Gorard DA. Persistently elevated alkaline phosphatase. BMJ Case Rep. 2012 Aug 24;2012
- 55. Assy N, Jacob G, Spira G, Edoute Y. Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol. 1999 Jun;5(3):252-262.
- 56. Revzin MV, Scoutt LM, Garner JG, Moore CL. Right Upper Quadrant Pain: Ultrasound First! J Ultrasound Med. 2017 Oct;36(10):1975-1985.
- 57. Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012 May;16(2):199-229.
- 58. Wadhwa V, Rai S, Thukral T, Chopra M. Laboratory quality management system: road to accreditation and beyond. Indian J Med Microbiol. 2012 Apr-Jun;30(2):131-40.
- 59. Allen LC. Role of a quality management system in improving patient safety - laboratory aspects. Clin Biochem. 2013 Sep;46(13-14):1187-93.
- 60. Ricós C, Fernandez-Calle P, Perich C, Westgard JO. Internal quality control - past, present and future trends. Adv Lab Med. 2022 Oct;3(3):243-262.
- 61. Loh TP, Lim CY, Sethi SK, Tan RZ, Markus C. Advances in internal quality control. Crit Rev Clin Lab Sci. 2023 Nov;60(7):502-517.
- 62. Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. J Clin Pathol. 2013 Dec;66(12):1027-32.
- 63. Yago M, Pla C. Reference-mean-centered statistical quality control. Clin Chem Lab Med. 2020 Aug 27;58(9):1517-1523.
- 64. Bruno LC. IQCP: Guideline and Helpful Tools for Implementation. Lab Med. 2016 Nov;47(4):e42-e46.
- 65. Khatri R, K C S, Shrestha P, Sinha JN. Implementing self sustained quality control procedures in a clinical laboratory. JNMA J Nepal Med Assoc. 2013 Jan-Mar;52(189):233-7.
- 66. Poh DKH, Lim CY, Tan RZ, Markus C, Loh TP. Internal quality control: Moving average algorithms outperform Westgard rules. Clin Biochem. 2021 Dec;98:63-69.
- 67. James D, Ames D, Lopez B, Still R, Simpson W, Twomey P. External quality assessment: best practice. J Clin Pathol. 2014 Aug;67(8):651-5.
- 68. Born PH, Thran SL. The influence of CLIA '88 on physician office laboratories. J Fam Pract. 1998 Apr;46(4):319-27.
- 69. Badrick T. Integrating quality control and external quality assurance. Clin Biochem. 2021 Sep;95:15-27.
- 70. Keckler MS, Anderson K, McAllister S, Rasheed JK, Noble-Wang J. Development and implementation of evidence-based laboratory safety management tools for a public health laboratory. Saf Sci. 2019 Aug;117:205-216.
- 71. Ialongo C, Bernardini S. Phlebotomy, a bridge between laboratory and patient. Biochem Med (Zagreb). 2016;26(1):17-33.
- 72. Tice AD. Bloodborne pathogen exposure and recommendations for management. J Infus Nurs. 2002 Nov-Dec;25(6 Suppl):S5-9.
- 73. Ta L, Gosa L, Nathanson DA. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank. Methods Mol Biol. 2019;1897:213-225.
- 74. Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013 Nov-Dec;128(6):498-509.
- 75. Noble MA. ISO 15190:2003 Medical Laboratories - Requirements for Safety. EJIFCC. 2004 Dec;15(4):141-143.
- 76. Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Keita MS, Rayfield MA, Peruski LF, Pierson A. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring. Health Secur. 2022 Nov-Dec;20(6):488-496.
References
1. Green MR, Sambrook J. Alkaline Phosphatase. Cold Spring Harb Protoc. 2020 Aug 03;2020(8):100768.
2. Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020 Sep 05;754:144855.
3. Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue Non-Specific Alkaline Phosphatase and Vascular Calcification: A Potential Therapeutic Target. Curr Cardiol Rev. 2019;15(2):91-95.
4. Zaher DM, El-Gamal MI, Omar HA, Aljareh SN, Al-Shamma SA, Ali AJ, Zaib S, Iqbal J. Recent advances with alkaline phosphatase isoenzymes and their inhibitors. Arch Pharm (Weinheim). 2020 May;353(5):e2000011.
5. Lallès JP. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev. 2014 Feb;72(2):82-94.
6. Dixon IMC. Tissue non-specific alkaline phosphatase (TNAP): A player in post-MI cardiac fibrosis. EBioMedicine. 2021 Jun;68:103430.
7. Brichacek AL, Brown CM. Alkaline phosphatase: a potential biomarker for stroke and implications for treatment. Metab Brain Dis. 2019 Feb;34(1):3-19.
8. Crofton PM. Biochemistry of alkaline phosphatase isoenzymes. Crit Rev Clin Lab Sci. 1982;16(3):161-94.
9. Matsushita M, Harajiri S, Tabata S, Yukimasa N, Muramoto Y, Komoda T. [Alkaline phosphatase activity in blood group B or O secretors is fluctuated by the dinner intake of previous night]. Rinsho Byori. 2013 Apr;61(4):307-12.
10. Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014 Jul;29(3):269-78.
11. Masrour Roudsari J, Mahjoub S. Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget's specimens. Caspian J Intern Med. 2012 Summer;3(3):478-83.
12. Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. Biochim Biophys Acta. 2013 Dec;1832(12):2044-56.
13. Wieczorek E. [Nocturnal intragastric administration of phosphates in the treatment of familial hypophosphatemic rickets]. Pediatr Pol. 1986 Sep;61(9):563-70.
14. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44(6):750-9.
15. McDonough PG. Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril. 2002 Apr;77(4):857-8.
16. Sancenon V, Goh WH, Sundaram A, Er KS, Johal N, Mukhina S, Carr G, Dhakshinamoorthy S. Development, validation and quantitative assessment of an enzymatic assay suitable for small molecule screening and profiling: A case-study. Biomol Detect Quantif. 2015 Jun;4:1-9.
17. Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER. A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem. 1983 May;29(5):751-61.
18. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013 Jan;257(1):27-36.
19. Siede WH, Seiffert UB. Quantitative alkaline phosphatase isoenzyme determination by electrophoresis on cellulose acetate membranes. Clin Chem. 1977 Jan;23(1):28-34.
20. Ni P, Xie J, Chen C, Jiang Y, Zhao Z, Zhang Y, Lu Y, Yu J. Spectrophotometric determination of the activity of alkaline phosphatase and detection of its inhibitors by exploiting the pyrophosphate-accelerated oxidase-like activity of nanoceria. Mikrochim Acta. 2019 May 02;186(5):320.
21. Wang J, Ni P, Chen C, Jiang Y, Zhang C, Wang B, Cao B, Lu Y. Colorimetric determination of the activity of alkaline phosphatase by exploiting the oxidase-like activity of palladium cube@CeO2 core-shell nanoparticles. Mikrochim Acta. 2020 Jan 09;187(2):115.
22. Warnes TW, Hine P, Kay G. Polyacrylamide gel disc electrophoresis of alkaline phosphatase isoenzymes in bone and liver disease. J Clin Pathol. 1976 Sep;29(9):782-7.
23. Milinković N, Sarić-Matutinović M, Pejanović S, Ignjatović S. Comparison between bone alkaline phosphatase immunoassay and electrophoresis technique in hemodialysis patients. J Med Biochem. 2020 Jan 23;39(2):178-183.
24. Rosalki SB, Foo AY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984 Jul;30(7):1182-6.
25. Moss DW. Alkaline phosphatase isoenzymes. Clin Chem. 1982 Oct;28(10):2007-16.
26. Iino S. [Clinical significance of alkaline phosphatase isozyme analysis]. Nihon Rinsho. 1995 May;53(5):1157-61.
27. Farley JR, Hall SL, Herring S, Libanati C, Wergedal JE. Reference standards for quantification of skeletal alkaline phosphatase activity in serum by heat inactivation and lectin precipitation. Clin Chem. 1993 Sep;39(9):1878-84.
28. Puukka R. Comparison of alkaline phosphatase isoenzymes determined by an inhibition method and by electrophoresis. Clin Chim Acta. 1978 Apr 17;85(2):111-4.
29. Fishman WH. Immunology and biochemistry of the Regan isoenzyme. Prostate. 1980;1(4):399-410.
30. Moss DW. Diagnostic aspects of alkaline phosphatase and its isoenzymes. Clin Biochem. 1987 Aug;20(4):225-30.
31. Nozawa S, Arai H, Widjaja T, Tsukazaki K, Ohta H, Kurihara S. [Biochemical studies on alkaline phosphatase isoenzyme profile in endometrial cancer]. Nihon Sanka Fujinka Gakkai Zasshi. 1984 Mar;36(3):369-76.
32. Jardillier JC. [The isoenzymes of the alkaline phosphatases and their cancerologic biochemistries prospects (author's transl)]. Ann Biol Clin (Paris). 1981;39(3):115-20.
33. Bowen RA, Remaley AT. Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb). 2014;24(1):31-44.
34. Knaak JB, Leung HW, Stott WT, Busch J, Bilsky J. Toxicology of mono-, di-, and triethanolamine. Rev Environ Contam Toxicol. 1997;149:1-86.
35. Niina N, Kodamatani H, Uozumi K, Kokufu Y, Saito K, Yamazaki S. Simultaneous detection of monoethanolamine, diethanolamine, and triethanolamine by HPLC with a chemiluminescence reaction and online derivatization to tertiary amine. Anal Sci. 2005 May;21(5):497-500.
36. Horning K, Schmidt C. Azathioprine-Induced Rapid Hepatotoxicity. J Pharm Technol. 2014 Feb;30(1):18-20.
37. Fraser MO, Arslan M, Plant TM. Androgen and estrogen treatment, alone or in combination, differentially influences bone maturation and hypothalamic mechanisms that time puberty in the male rhesus monkey (Macaca mulatta). Pediatr Res. 2005 Jan;57(1):141-8.
38. Sjödén G, Rosenqvist M, Kriegholm E, Nordenström J, Björkhem I. Verapamil increases serum alkaline phosphatase in hypertensive patients. J Intern Med. 1990 Oct;228(4):339-42.
39. David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev. 2010 Jan 01;6:73-80.
40. Wang Z, Guo H, Wang Y, Kong F, Wang R. Interfering effect of bilirubin on the determination of alkaline phosphatase. Int J Clin Exp Med. 2014;7(11):4244-8.
41. Pyles LA, Stejskal EJ, Einzig S. Spectrophotometric measurement of plasma 2-thiobarbituric acid-reactive substances in the presence of hemoglobin and bilirubin interference. Proc Soc Exp Biol Med. 1993 Apr;202(4):407-19.
42. Stigbrand T. Present status and future trends of human alkaline phosphatases. Prog Clin Biol Res. 1984;166:3-14.
43. Martin JM, Goldberg DM. Activities of gamma-glutamyl transferase, 5'-nucleotidase and alkaline phosphatase in human duodenal aspirate. Enzyme. 1986;35(4):189-96.
44. Takeuchi A, Shibuya A. [5'-Nucleotidase]. Nihon Rinsho. 1999 Aug;57 Suppl:483-5.
45. Shamban L, Patel B, Williams M. Significantly Elevated Liver Alkaline Phosphatase in Congestive Heart Failure. Gastroenterology Res. 2014 Apr;7(2):64-68.
46. Gao Y, Chin K, Mishriki YY. AIDS Cholangiopathy in an Asymptomatic, Previously Undiagnosed Late-Stage HIV-Positive Patient from Kenya. Int J Hepatol. 2011;2011:465895.
47. Šmíd V. Liver tests. Cas Lek Cesk. 2022 Spring;161(2):52-56.
48. Demers LM, Costa L, Lipton A. Biochemical markers and skeletal metastases. Cancer. 2000 Jun 15;88(12 Suppl):2919-26.
49. Fontes-Sousa M, Magalhães H, da Silva FC, Maurício MJ. Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria. Urol Oncol. 2018 Jul;36(7):321-326.
50. Sakurai Y, Higashiguchi T. Transient hyperphosphatasemia: Possible association with pediatric acute respiratory infection. Pediatr Investig. 2021 Jun;5(2):94-98.
51. Whyte MP. Hypophosphatasia: An overview For 2017. Bone. 2017 Sep;102:15-25.
52. Arthur LJ, Hill PG, Attenburrow AA. Transient hyperphosphatasaemia. Arch Dis Child. 1984 Oct;59(10):996-7.
53. Schonhaut B L, Rocha R A. [Benign transient hyperphosphatasaemia in infants: Clinical series]. Rev Chil Pediatr. 2017 Feb;88(1):169-175.
54. Verma J, Gorard DA. Persistently elevated alkaline phosphatase. BMJ Case Rep. 2012 Aug 24;2012
55. Assy N, Jacob G, Spira G, Edoute Y. Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol. 1999 Jun;5(3):252-262.
56. Revzin MV, Scoutt LM, Garner JG, Moore CL. Right Upper Quadrant Pain: Ultrasound First! J Ultrasound Med. 2017 Oct;36(10):1975-1985.
57. Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012 May;16(2):199-229.
58. Wadhwa V, Rai S, Thukral T, Chopra M. Laboratory quality management system: road to accreditation and beyond. Indian J Med Microbiol. 2012 Apr-Jun;30(2):131-40.
59. Allen LC. Role of a quality management system in improving patient safety - laboratory aspects. Clin Biochem. 2013 Sep;46(13-14):1187-93.
60. Ricós C, Fernandez-Calle P, Perich C, Westgard JO. Internal quality control - past, present and future trends. Adv Lab Med. 2022 Oct;3(3):243-262.
61. Loh TP, Lim CY, Sethi SK, Tan RZ, Markus C. Advances in internal quality control. Crit Rev Clin Lab Sci. 2023 Nov;60(7):502-517.
62. Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. J Clin Pathol. 2013 Dec;66(12):1027-32.
63. Yago M, Pla C. Reference-mean-centered statistical quality control. Clin Chem Lab Med. 2020 Aug 27;58(9):1517-1523.
64. Bruno LC. IQCP: Guideline and Helpful Tools for Implementation. Lab Med. 2016 Nov;47(4):e42-e46.
65. Khatri R, K C S, Shrestha P, Sinha JN. Implementing self sustained quality control procedures in a clinical laboratory. JNMA J Nepal Med Assoc. 2013 Jan-Mar;52(189):233-7.
66. Poh DKH, Lim CY, Tan RZ, Markus C, Loh TP. Internal quality control: Moving average algorithms outperform Westgard rules. Clin Biochem. 2021 Dec;98:63-69.
67. James D, Ames D, Lopez B, Still R, Simpson W, Twomey P. External quality assessment: best practice. J Clin Pathol. 2014 Aug;67(8):651-5.
68. Born PH, Thran SL. The influence of CLIA '88 on physician office laboratories. J Fam Pract. 1998 Apr;46(4):319-27.
69. Badrick T. Integrating quality control and external quality assurance. Clin Biochem. 2021 Sep;95:15-27.
70. Keckler MS, Anderson K, McAllister S, Rasheed JK, Noble-Wang J. Development and implementation of evidence-based laboratory safety management tools for a public health laboratory. Saf Sci. 2019 Aug;117:205-216.
71. Ialongo C, Bernardini S. Phlebotomy, a bridge between laboratory and patient. Biochem Med (Zagreb). 2016;26(1):17-33.
72. Tice AD. Bloodborne pathogen exposure and recommendations for management. J Infus Nurs. 2002 Nov-Dec;25(6 Suppl):S5-9.
73. Ta L, Gosa L, Nathanson DA. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank. Methods Mol Biol. 2019;1897:213-225.
74. Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013 Nov-Dec;128(6):498-509.
75. Noble MA. ISO 15190:2003 Medical Laboratories - Requirements for Safety. EJIFCC. 2004 Dec;15(4):141-143.
76. Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Keita MS, Rayfield MA, Peruski LF, Pierson A. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring. Health Secur. 2022 Nov-Dec;20(6):488-496.